Life Science Company News

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Nicox: 2024 Ordinary Shareholder Meeting to be held on June 28th, 2024

Read more ››
By: GlobeNewswire - 24 May 2024

Lift BioSciences Announces Abstract Publications at the American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: GlobeNewswire - 24 May 2024

Atrogi Announces Publication on Advancements in Combatting Obesity and Metabolic Complications

Read more ››
By: GlobeNewswire - 24 May 2024

Enterome Highlights High Complete Response Rate in Clinical Study of EO2463 for Indolent Non-Hodgkin Lymphoma at ASCO 2024

Read more ››
By: GlobeNewswire - 24 May 2024

United in Our Fight Against Cancer - New Frontier Group Acquires Hong Kong Integrated Oncology Centre

Read more ››
By: PR Newswire Association LLC. - 24 May 2024

Compassionate closure for those who are unable to fulfil hopes and expectations of fertility treatment

Read more ››
By: PR Newswire Association LLC. - 24 May 2024

Dizal Reveals New Findings from Biomarker Analysis, Highlighting Sunvozertinib as an Effective Treatment for Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

Read more ››
By: PR Newswire Association LLC. - 24 May 2024

Tyligand Bioscience Announces First Patient Dosed in Phase 1/2 Clinical Trial of TSN1611, a Selective and Orally Bioavailable KRAS G12D Inhibitor

Read more ››
By: PR Newswire Association LLC. - 24 May 2024

JPA HEALTH EXPANDS CAPABILITIES WITH THE ACQUISITION OF BIOCENTRIC, INC.

Read more ››
By: PR Newswire Association LLC. - 24 May 2024

Gateway Foundation Announces Grant Funding Opportunity Following Closure of Historic Beacon House

Read more ››
By: PR Newswire Association LLC. - 24 May 2024

STORM Therapeutics to Present Interim Phase 1 Clinical Data on its METTL3 RNA Methyltransferase Inhibitor STC-15 at ASCO 2024

Read more ››
By: PR Newswire Association LLC. - 24 May 2024

Mycotoxin Testing Market worth $2.3 billion by 2029 - Exclusive Report by MarketsandMarkets™

Read more ››
By: PR Newswire Association LLC. - 24 May 2024

Menarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2024 Annual Meeting

Read more ››
By: PR Newswire Association LLC. - 24 May 2024

Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024

Read more ››
By: GlobeNewswire - 24 May 2024

Antengene To Present One Oral and Four Abstracts at ASCO 2024

Read more ››
By: PR Newswire Association LLC. - 24 May 2024

Busting fear barrier about hormone replacement therapy in new era of menopause management

Read more ››
By: PR Newswire Association LLC. - 24 May 2024

CStone Announces Abstract Release of CS5001 (ROR1 ADC) First-in-Human Clinical Data on ASCO Website

Read more ››
By: PR Newswire Association LLC. - 24 May 2024

The Art of Living Rehabilitates Prison Inmates

Read more ››
By: PR Newswire Association LLC. - 24 May 2024

Heart to Heart Hospice of San Antonio Opens New Hospice House

Read more ››
By: PR Newswire Association LLC. - 24 May 2024

ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates

Read more ››
By: PR Newswire Association LLC. - 24 May 2024
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate